Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
35
days
Myelofibrosis treatment sequencing: mutation-informed risk and optimal JAK inhibitor discontinuation
Authors
Giulia Benevolo; Giuseppe Lanzarone; Benedetta Rosti; Eloise BeggiatoShow moreShow less
Affiliations
1. Città della Salute e della ScienzaShow moreShow less
93
days
Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies
Authors
Johnny MahlanguShow moreShow less
Affiliations
1. University of the WitwatersrandShow moreShow less
49
days
Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment
Authors
Catherine M. Broome; Bruno FattizzoShow moreShow less
Affiliations
1. MedStar Georgetown University; 2. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; 3. University of MilanShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
